Cardiovascular disease remains a leading cause of mortality in the US, despite years of progress in encouraging prevention efforts. A recent webinar moderated by Viet Le, PA-C, associate professor of research at Intermountain Health, highlighted the need for personalized risk assessments and emerging treatments to combat this health crisis.
The discussion emphasized the importance of coronary calcium scores and uric acid levels in assessing cardiovascular risk. Panelists also discussed lifestyle changes such as structured exercise and dietary modifications. Gulati explained that the developing understanding of cardiovascular kidney metabolic health is a foundation for general or preventive cardiology.
Bailey outlined two major barriers to preventing cardiovascular diseases: lack of action until an event occurs, and limited access to care. Bailey noted that cardiologists often do not meet with patients until they have been dealing with uncontrolled lipids or hypertension for 20 years. The panel also discussed the role of lipoprotein(a) (Lp[a)) in increasing atherogenic risk.
Wong emphasized the need for increased awareness about Lp(a) testing, citing recent data that fewer than 1% of patients get tested. New recommendations from the National Lipid Association call for adults to get tested for Lp(a) at least once in their life.
The panelists also discussed emerging risk factors and strategies for personalizing risk assessments. The discussion emphasized the importance of addressing risk and starting treatment when a high-risk patient is identified.
As the US continues to grapple with the leading cause of mortality, experts emphasize the need for personalized risk assessments and emerging treatments to combat cardiovascular disease. By prioritizing prevention efforts and addressing barriers to care, we can work towards reducing this devastating health crisis.
Source: https://www.ajmc.com/view/addressing-cardiovascular-risk-and-intervening-early-recording